https://smartstudien.se/intervju-med-professor-per-hall-i-cancerfondens-podd-glod/2024-03-15T15:04:50+01:00https://smartstudien.se/riskbaserad-screening-intervju-i-dn-med-professor-per-hall/2024-03-15T15:06:13+01:00https://smartstudien.se/karma-projektet-stottar-prevcan/2024-03-15T15:12:49+01:00https://smartstudien.se/brostcancerrapporten-2022-radda-fler-liv-med-individanpassad-screening/2024-03-15T15:13:57+01:00https://smartstudien.se/tema-brostcancer-i-fraga-doktorn-pa-svt/2024-03-15T14:40:20+01:00https://smartstudien.se/karma-pa-plats-under-san-antonio-breast-cancer-symposium/2024-03-15T15:00:09+01:00https://smartstudien.se/prevcan-satter-fokus-pa-screening-under-september/2024-03-15T15:11:30+01:00https://smartstudien.se/mammografisk-tathet-och-ai-intervju-i-tv4/2024-10-21T09:39:54+02:00https://smartstudien.se/tata-brost-och-riskbaserad-screening/2024-12-12T10:19:37+01:00https://smartstudien.se/smart-studien-och-brostcancerforbundet/2024-12-13T10:05:47+01:00https://smartstudien.se/om-smart-studien-i-tidningen-mitt-i/2025-06-16T08:51:52+02:00https://smartstudien.se/debattartikel-i-dagens-medicin-mer-forskning-ar-nyckeln-till-att-bota-cancer/2025-10-01T14:24:40+02:00https://smartstudien.se/en-milstolpe-i-smart-studien/2026-03-17T14:36:12+01:00